Aequus Pharmaceuticals Inc.

TSXV:AQS Stock Report

Market Cap: CA$663.2k

Aequus Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 0/6

Aequus Pharmaceuticals has a total shareholder equity of CA$-6.2M and total debt of CA$5.9M, which brings its debt-to-equity ratio to -95.3%. Its total assets and total liabilities are CA$858.0K and CA$7.1M respectively.

Key information

-95.3%

Debt to equity ratio

CA$5.93m

Debt

Interest coverage ration/a
CashCA$25.41k
Equity-CA$6.22m
Total liabilitiesCA$7.08m
Total assetsCA$858.02k

Recent financial health updates

Recent updates

Health Check: How Prudently Does Aequus Pharmaceuticals (CVE:AQS) Use Debt?

Mar 21
Health Check: How Prudently Does Aequus Pharmaceuticals (CVE:AQS) Use Debt?

Is Aequus Pharmaceuticals (CVE:AQS) Using Debt Sensibly?

Nov 05
Is Aequus Pharmaceuticals (CVE:AQS) Using Debt Sensibly?

Is Aequus Pharmaceuticals (CVE:AQS) Using Too Much Debt?

Dec 17
Is Aequus Pharmaceuticals (CVE:AQS) Using Too Much Debt?

Financial Position Analysis

Short Term Liabilities: AQS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: AQS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: AQS has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: AQS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AQS has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AQS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 3.6% each year


Discover healthy companies